0001209191-16-091409.txt : 20160114
0001209191-16-091409.hdr.sgml : 20160114
20160114161121
ACCESSION NUMBER: 0001209191-16-091409
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160112
FILED AS OF DATE: 20160114
DATE AS OF CHANGE: 20160114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerulean Pharma Inc.
CENTRAL INDEX KEY: 0001401914
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: 5TH FLOOR
CITY: Cambridge
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-551-9600
MAIL ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: 5TH FLOOR
CITY: Cambridge
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WALT DAVID R
CENTRAL INDEX KEY: 0001205236
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36395
FILM NUMBER: 161343094
MAIL ADDRESS:
STREET 1: 5200 ILLUMINA WAY
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-01-12
0
0001401914
Cerulean Pharma Inc.
CERU
0001205236
WALT DAVID R
C/O CERULEAN PHARMA INC.
35 GATEHOUSE DRIVE
WALTHAM
MA
02451
1
0
0
0
Common Stock
2016-01-12
4
P
0
4300
2.8872
A
58247
D
Common Stock
2016-01-13
4
P
0
4384
2.6902
A
62631
D
These purchases were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2015.
Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $2.82 to $3.00 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $2.53 to $2.79 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
/s/ Alejandra Carvajal, as attorney-in-fact for David R. Walt
2016-01-14